Importantly, PTNK treatment of DCM sera prevented serum-induced pathological gene expression changes with a decrease in BNP (P < 0.0001) and ANF (P = 0.046) and an increase in the α-MyHC/β-MyHC ratio (P < 0.0001). The gene discussed is MYH6; the disease is familial dilated cardiomyopathy.